Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,062 | -4,076 | -4,658 | -6,638 | -3,156 |
| Depreciation Amortization | 1,864 | 1,466 | 1,239 | 807 | 127 |
| Accounts payable and accrued liabilities | -217 | 43 | 161 | 557 | 569 |
| Other Working Capital | 532 | 566 | 442 | 1,094 | 934 |
| Other Operating Activity | 2,559 | 2,261 | 2,847 | 1,900 | 190 |
| Operating Cash Flow | $-1,324 | $259 | $32 | $-2,281 | $-1,336 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | N/A | 189 | 183 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $189 | $183 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 320 | 320 | N/A | N/A | 148 |
| Debt Issued | N/A | N/A | 70 | 2,088 | N/A |
| Common Stock Issued | 2,305 | N/A | N/A | 83 | 83 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 936 |
| Financing Cash Flow | $2,625 | $320 | $70 | $2,171 | $1,167 |
| Beginning Cash Position | 82 | 82 | 82 | 3 | 3 |
| End Cash Position | 1,382 | 661 | 183 | 82 | 16 |
| Net Cash Flow | $1,300 | $579 | $102 | $80 | $14 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,324 | 259 | 32 | -2,281 | -1,336 |
| Free Cash Flow | -1,324 | 259 | 32 | -2,281 | -1,336 |